Cargando…
Development and Validation of a Docking-Based Virtual Screening Platform for the Identification of New Lactate Dehydrogenase Inhibitors
The human muscle isoform of lactate dehydrogenase (hLDH5) is one of the key enzymes of the glycolytic process. It is overexpressed in metastatic cancer cells and is linked to the vitality of tumors in hypoxic conditions. With the aim of identifying new hLDH5 inhibitors, a fully automated docking-bas...
Autores principales: | Granchi, Carlotta, Capecchi, Alice, Del Frate, Gianluca, Martinelli, Adriano, Macchia, Marco, Minutolo, Filippo, Tuccinardi, Tiziano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272605/ https://www.ncbi.nlm.nih.gov/pubmed/25988609 http://dx.doi.org/10.3390/molecules20058772 |
Ejemplares similares
-
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
por: Granchi, Carlotta, et al.
Publicado: (2017) -
Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
por: Jha, Vibhu, et al.
Publicado: (2020) -
Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors
por: Poli, Giulio, et al.
Publicado: (2017) -
New PIN1 inhibitors identified through a pharmacophore-driven, hierarchical consensus docking strategy
por: Poli, Giulio, et al.
Publicado: (2021) -
Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death
por: Daniele, Simona, et al.
Publicado: (2015)